Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol

Peer Review reports

Original Submission
28 Jun 2021	Submitted	Original manuscript
28 Jul 2021	Author responded	Author comments - Yvette N Löwensteyn
Resubmission - Version 2
28 Jul 2021	Submitted	Manuscript version 2
2 Aug 2021	Author responded	Author comments - Yvette N Löwensteyn
Resubmission - Version 3
2 Aug 2021	Submitted	Manuscript version 3
Publishing
6 Aug 2021	Editorially accepted
23 Aug 2021	Article published	10.1186/s12879-021-06544-3

Back to article page